Histamine analogue (vestibular)
Betahistine dihydrochloride
Brand names: Serc
Adult dose
Dose: 16mg TDS or 8–16mg TDS; titrate to response
Route: Oral
Frequency: TDS
Clinical pearls
- NICE CKS / ENT UK Ménière's disease: long-term symptomatic control of vertigo
- Limited high-quality evidence; used widely in UK practice
- Specialist initiation often required
Contraindications
- Phaeochromocytoma
- Active peptic ulcer
- Asthma (caution)
- Hypersensitivity
Side effects
- GI upset
- Headache
- Skin rash
- Bronchospasm (asthma)
Interactions
- Antihistamines (theoretical antagonism)
Monitoring
- Symptom diary
- Hearing
- Tinnitus
Reference: BNF; NICE CKS Ménière's; ENT UK; https://bnf.nice.org.uk/drugs/betahistine-dihydrochloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020